Funding opportunities

Below is a list of funding opportunities that may be relevant for thoracic cancer research, including basic scientific research. Please read the funding guidelines to determine if your research proposal is eligible and that you meet other eligibility requirements.

Any TOGA member can apply for TOGA endorsement of their thoracic cancer research proposal, taking advantage of peer- and consumer-review by TOGA working groups in the following areas:

  1. Early non small cell lung cancer
  2. Advanced non small cell lung cancer
  3. Small cell lung cancer/mesothelioma
  4. Supportive and palliative care
  5. Translational research

TOGA endorsement offers the following benefits:

  • Use of TOGA logo or TOGA acknowledgment on all applications, presentations and publications
  • Membership mailouts to assist with recruitment
  • Listing of trial on the TOGA website
  • Updates presented at Scientific Committee or other TOGA meetings (time permitting)

Further information is available in the TOGA Endorsement Policy.

The next deadline for submission of concepts for peer- and consumer review and application for endorsement will be posted on social media and circulated in a members’ newsletter. Send concepts at any time to info@thoraciconcology.org.au

If you know of additional funding opportunities that we can list, please contact info@thoraciconcology.org.au

Grant NameResearch fundedGrant open dateClose dateMax fundingDurationApplication requirements
GO5855 MRFF 2022 Frontier Health and Medical Research Grant OpportunityProgram of research comprising a series of linked projects in a currently serious and incurable health condition. The program aims to create a treatment/means of prevention through development of novel health technologies and/or re-purposing existing health technologies in a novel way.13/02/2023
Currently open
Full Application 31 March 2026 (17:00 ACT time)$25 million5 yearsComplete the online expression of interest/application form

Full applications subject to invitation.
Gilead Australia Fellowship Grants ProgramThe Gilead Australia Fellowship Program is inviting applications focused on improving the care and outcomes of people living with breast, lung and bladder cancer via a variety of projects.4 March 202426 April 2024$60,00018 monthsApplications must be submitted online via the Gilead grants portal
Ramaciotti Health Investment GrantIndividuals in universities, public hospitals or institutes for a contribution towards the undertaking of health or medical research with the potential path to clinical application within five years. 4 March 202431 May 2024Up to $100,000Once only basis with paymentGuidelines



Submit Application
Viertel Foundation Senior Medical Research FellowshipsNo particular priority areas other than health and medical research. Grant is intended to provide a full time salary and equipment costs.Currently openApril 30 2024$1,375,000
3 fellowships available
5 years commencing 20254-10 years post doc; no full time salary from another source
Application guidelines
Viertel Foundation Clinical Investigator AwardsGrant is intended to support research project costs only. Applicants should be actively engaged in clinical research.Currently openApril 30 2024$90,000
5 available
Once only basis with payment made in ~ January 2025Medical graduates or graduates of other clinical disciplines in a clinical position for not more than 36 months.
Application guidelines
GO6540 MRFF 2023 Clinical Trials Activity Grant OpportunityThe Clinical Trials Activity Initiative (the Initiative) aims to:
- improve the evidence base supporting clinical care
- help patients access trials relevant to their health circumstances
- enable researchers to bring international trials to Australian patients
25 October 2023
Currently open
Minimum data 1 May 2024
(17:00 ACT time)
Full application 29 May 2024
(17:00 ACT time)
Up to $5 millionUp to 5 yearsApplication form submitted through Sapphire
GO6578 – 2023 Innovative Trials National Critical Research Infrastructure Initiative Various opportunities examining:
-feasibility of national adaptive platform trials
-establishment or expansion of a national adaptive trial in an area of unmet need
-Conduct a registry-randomised trial in an area of unmet need
-Evidence of efficiency/cost effectiveness of registry randomised trials or adaptive trial platforms over conventional trial designs
6 February 202410-Jul-2024 5:00 pm (ACT Local Time)Up to $5 million2 yearscomplete the online program application form

GO6361 NHMRC-EU Collaborative Research Grant Scheme 2024Projects involving Australian-based researchers chosen by the EU for funding may be eligible for NHMRC support. NHMRC is considering supporting Australian researchers for Horizon Europe submitted through the two-stage deadline model.12 July 2023
Currently open
16 October 2024 (17:00 ACT time)$1 Million5 yearsApplication form submitted through Sapphire
MRFF - 2024 International Clinical Trial Collaborations Grant OpportunityAustralian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.6 March 2024Min data 31 July 2024 (17:00 ACT time)
Full application due 4 December 2024 (17:00 ACT time)
$3 million5 yearsApplicants are advised to read the Grant Guidelines.

Applications must be submitted using Sapphire, the NHMRC's grant system.